biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Dec 11, 2017 4:27pm

129 Views

Post# 27133325

RE:RE:looks like

Anyone else think that drjekyl is a complete a$$?

Sniper007, I thought Jekyl's post was pretty informative. He's telling us that tax loss selling will continue until it ends and that we can buy or sell shares if we want to.

He's also reconfirming that he's too helpless to find out what is currently happening.

That's a lot for one post!

I was a little surprised that he said nothing about RH and the prior board given that his main contribution is whining and complaining about old news and events from years gone by.

Bullboard Posts

Options trading in a volatile macro environment